DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

A podcast by DrugPatentWatch - Fridays

Categories:

Business

160 Episodes

  1. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  2. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  3. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  4. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  5. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  6. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  7. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  8. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  9. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  10. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  11. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  12. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  13. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  14. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  15. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  16. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  17. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  18. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  19. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

  20. Unleashing Innovation: The Case for Permissionless R&D in Pharma

    Published: 3/22/2024

1 / 8

DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management